NICE to seek greater access to clinical trial data when appraising drugs
NICE will ask for access to clinical trial data from the European regulatory authorities if pharmaceutical companies fail to supply all the relevant data.
Latest news headlines
Every hospital should appoint an intravenous (IV) fluids lead to help ensure that patients receive the correct dosage and type of fluid, says NICE.
14 August 2014
Leading cancer charities have joined NICE in calling on Roche to lower the price for its advanced breast cancer drug Kadcyla (trastuzumab emtansine).
08 August 2014
A series of annual checks to monitor and improve the health of people with diabetes are among measures proposed by NICE for its latest Quality and Outcomes Framework (QOF) indicator menu.
01 August 2014
NICE’s quality standard for hepatitis B can help to reduce the spread of the infection by ensuring that people who are at increased risk are offered testing and vaccination.
28 July 2014
NICE has updated its clinical guideline on chronic kidney disease (CKD) to include new recommendations on the diagnosis and classification of the condition, and on its relationship with acute kidney injury.
23 July 2014
Up to 8,000 lives could be saved every three years by offering statins to anyone with a 10 per cent risk of developing cardiovascular disease (CVD) within a decade, says NICE.
18 July 2014